How Much Did RAUMEDIC Raise?
Funding & Key Investors

RAUMEDIC has solidified its position as a cornerstone of the global medical technology supply chain, recently securing a major strategic investment. This capital infusion, totaling $1M, underscores the firm's critical role in the advancement of high-precision healthcare components. With a cumulative financial backing of $1M, the organization continues to leverage its deep-rooted expertise in material science to meet the evolving demands of the international pharmaceutical and clinical sectors.

What is RAUMEDIC?

RAUMEDIC
ManufacturingMedical Devices & EquipmentPlastic, Packaging & Containers

Headquartered with a robust footprint across Germany and the United States, RAUMEDIC operates at the intersection of advanced polymer engineering and patient-centric innovation. The company specializes in the processing of medical-grade thermoplastic polymers and silicones, utilizing seven decades of technical proficiency in extrusion, injection molding, and complex assembly. By serving as a strategic partner to global medical technology firms, RAUMEDIC facilitates the transition from conceptual design to mature, market-ready products. Their portfolio is particularly distinguished by high-precision pressure-measuring systems integrated with microchip technology, which are essential for modern neuromonitoring and traumatology applications. This technical capability ensures that the company remains an indispensable link in the global healthcare value chain, supporting safe and effective patient outcomes through rigorous manufacturing standards.

How much funding has RAUMEDIC raised?

RAUMEDIC has raised a total of $1M across 1 funding round:

2020

Debt

$1M

Debt (2020): $1M with participation from PPP

Key Investors in RAUMEDIC

PPP

Public-Private Partnership

What's next for RAUMEDIC?

The recent influx of capital is expected to accelerate RAUMEDIC's strategic initiatives, particularly in the scaling of its production capabilities for complex diagnostic and therapeutic systems. As the medical device industry shifts toward more integrated, smart-component architectures, RAUMEDIC is well-positioned to expand its R&D efforts in microchip-enabled medical hardware. The company will likely focus on deepening its penetration into the North American and European markets, optimizing its five production sites to enhance supply chain resilience. By prioritizing the development of next-generation catheters and tubing systems, RAUMEDIC aims to maintain its competitive edge, ensuring that its polymer-based solutions continue to set the benchmark for reliability and precision in clinical environments worldwide.

See full RAUMEDIC company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Chemicals & Related ProductsManufacturing
Industrial Machinery & EquipmentManufacturingCleaning Products
ManufacturingMedical Devices & EquipmentBusiness ServicesResearch & Development
Industrial Machinery & EquipmentManufacturingPlastic, Packaging & Containers

Frequently Asked Questions Regarding RAUMEDIC Financial Insights

What are the most recent funding rounds that RAUMEDIC has completed, and what were the funding rounds?
RAUMEDIC has recently completed 1 funding rounds: Debt on May 2, 2020.
What is the total amount of funding RAUMEDIC has raised to date?
RAUMEDIC has raised a total of $1M in funding to date.
How many funding rounds has RAUMEDIC completed?
RAUMEDIC has completed 1 funding rounds.
How much funding did RAUMEDIC raise in its most recent funding round?
RAUMEDIC raised $1M in its most recent funding round.
Who are the lead investors in RAUMEDIC's latest funding round?
The lead investor in RAUMEDIC's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in RAUMEDIC's history?
The largest funding round in RAUMEDIC's history was $1M.
See more information about RAUMEDIC